BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21972422)

  • 21. Cytokine receptor-like factor 1 is highly expressed in damaged human knee osteoarthritic cartilage and involved in osteoarthritis downstream of TGF-beta.
    Tsuritani K; Takeda J; Sakagami J; Ishii A; Eriksson T; Hara T; Ishibashi H; Koshihara Y; Yamada K; Yoneda Y
    Calcif Tissue Int; 2010 Jan; 86(1):47-57. PubMed ID: 19921088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease.
    Wang SJ; Guo X; Zuo H; Zhang YG; Xu P; Ping ZG; Zhang Z; Geng D
    J Rheumatol; 2006 Mar; 33(3):615-9. PubMed ID: 16511931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability.
    Kinkel MD; Horton WE
    J Cell Biochem; 2003 Apr; 88(5):941-53. PubMed ID: 12616533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
    Chang JK; Chang LH; Hung SH; Wu SC; Lee HY; Lin YS; Chen CH; Fu YC; Wang GJ; Ho ML
    Arthritis Rheum; 2009 Oct; 60(10):3049-60. PubMed ID: 19790062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis.
    Yudoh K; Nakamura H; Masuko-Hongo K; Kato T; Nishioka K
    Arthritis Res Ther; 2005; 7(4):R904-14. PubMed ID: 15987493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J; Ryan LM; Masuda I
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis.
    Salminen H; Vuorio E; Säämänen AM
    Arthritis Rheum; 2001 Apr; 44(4):947-55. PubMed ID: 11315934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes.
    Millward-Sadler SJ; Wright MO; Davies LW; Nuki G; Salter DM
    Arthritis Rheum; 2000 Sep; 43(9):2091-9. PubMed ID: 11014361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear accumulation of prohibitin 1 in osteoarthritic chondrocytes down-regulates PITX1 expression.
    Picard C; Pellicelli M; Taheri M; Lavoie JF; Doucet R; Wang D; Bernard L; Bouhanik S; Lavigne P; Moreau A
    Arthritis Rheum; 2013 Apr; 65(4):993-1003. PubMed ID: 23310948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic changes in articular cartilage of human endemic osteoarthritis in China.
    Ma WJ; Guo X; Liu JT; Liu RY; Hu JW; Sun AG; Yu YX; Lammi MJ
    Proteomics; 2011 Jul; 11(14):2881-90. PubMed ID: 21681992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
    Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
    J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers.
    van der Windt AE; Haak E; Kops N; Verhaar JA; Weinans H; Jahr H
    Arthritis Rheum; 2012 Jun; 64(6):1929-39. PubMed ID: 22231955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
    Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
    Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of deleted in colon carcinoma in osteoarthritis and in chondrocyte migration.
    Schubert T; Kaufmann S; Wenke AK; Grässel S; Bosserhoff AK
    Rheumatology (Oxford); 2009 Nov; 48(11):1435-41. PubMed ID: 19745029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.
    Alaaeddine N; Olee T; Hashimoto S; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Jul; 44(7):1633-43. PubMed ID: 11465714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
    Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
    Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW; Lou SQ; Zhang K
    Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV; Squires G; Poole AR
    J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.